NCT07099586

Brief Summary

This cross-sectional observational study aims to assess serum concentrations of vitamin B12, folic acid, and vitamin D in women of reproductive age in Herzegovina. The study is led by Professor Vajdana Tomić, MD, PhD, who serves as the Principal Investigator, at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina. The goal is to determine whether current international supplementation guidelines reflect the actual micronutrient status of this population. A total of 360 women aged 18-49 will be enrolled between December 2024 and December 2025 after providing informed consent. The findings will inform population-specific recommendations for micronutrient supplementation during the preconception period and pregnancy. The study will be conducted at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 20, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

July 25, 2025

Last Update Submit

July 25, 2025

Conditions

Keywords

vitamin B12vitamin Dfolic acid

Outcome Measures

Primary Outcomes (3)

  • Serum concentration of vitamin B12

    Measured in serum samples using Alinity i immunoassay system.

    At enrollment (single visit)

  • Serum concentration of folic acid

    Measured in serum samples using Alinity i immunoassay system.

    At enrollment (single visit)

  • Serum concentration of vitamin D

    Measured in serum samples using Alinity i immunoassay system.

    At enrollment (single visit)

Study Arms (1)

Women of Reproductive Age

This cohort includes women aged 18 to 49 years who are undergoing blood sampling for analysis of serum concentrations of vitamin B12, folic acid, and vitamin D. No interventions are administered. This is an observational, cross-sectional study.

Other: No Interventions

Interventions

This is an observational study. No intervention will be administered. Participants will provide blood samples for micronutrient analysis.

Women of Reproductive Age

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study includes approximately 360 women aged 18 to 49 years from the Herzegovina region who participate after providing written informed consent. All participants are being screened according to defined inclusion and exclusion criteria. The study focuses on assessing serum concentrations of vitamin B12, folic acid, and vitamin D to support the development of population-specific supplementation guidelines for the preconception period and pregnancy.

You may qualify if:

  • Women of reproductive age (18-49 years)
  • Informed consent obtained

You may not qualify if:

  • diabetes (Type I or II)
  • epilepsy
  • oncological diseases, inflammatory bowel disease
  • supplementation with vitamin B12, folic acid, or vitamin D within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Mostar

Mostar, 88000, Bosnia and Herzegovina

RECRUITING

Central Study Contacts

Vajdana Tomić, professor, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 1, 2025

Study Start

December 20, 2024

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to privacy concerns and institutional policy limitations. All data will be analyzed and presented in aggregate form only, without identifying individual participants.

Locations